135 related articles for article (PubMed ID: 642829)
41. Glucose regulation of lipid metabolism in humans.
Carlson MG; Snead WL; Hill JO; Nurjhan N; Campbell PJ
Am J Physiol; 1991 Dec; 261(6 Pt 1):E815-20. PubMed ID: 1767842
[TBL] [Abstract][Full Text] [Related]
42. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
Mauriège P; Klein Kranenbarg WM; Prud'homme D; Lamarche B; Tremblay A; Bouchard C; Nadeau A; Després JP
Int J Obes Relat Metab Disord; 1996 Jul; 20(7):668-76. PubMed ID: 8817361
[TBL] [Abstract][Full Text] [Related]
43. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
44. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
[TBL] [Abstract][Full Text] [Related]
45. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
46. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
Galloway SD; Craig TP; Cleland SJ
Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
[TBL] [Abstract][Full Text] [Related]
47. Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans.
Reeds DN; Stuart CA; Perez O; Klein S
Metabolism; 2006 Dec; 55(12):1658-63. PubMed ID: 17142140
[TBL] [Abstract][Full Text] [Related]
48. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance.
van Beek L; Lips MA; Visser A; Pijl H; Ioan-Facsinay A; Toes R; Berends FJ; Willems van Dijk K; Koning F; van Harmelen V
Metabolism; 2014 Apr; 63(4):492-501. PubMed ID: 24467914
[TBL] [Abstract][Full Text] [Related]
49. [Studies on lipid mobilization in obesity without glucose intolerance. 1st communication. Noradrenaline-stimulated lipolysis].
Ratzmann KP; Paul I; Meyer LW; Müller F
Endokrinologie; 1975 Dec; 66(3):337-47. PubMed ID: 1212997
[TBL] [Abstract][Full Text] [Related]
50. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
51. The effect of norepinephrine and theophylline on blood glucose, plasms FFA, plasma glycerol and plasma insulin in normal subjects.
Arnman K; Carlström S; Thorell JI
Acta Med Scand; 1975 Apr; 197(4):271-4. PubMed ID: 1136854
[TBL] [Abstract][Full Text] [Related]
52. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
[TBL] [Abstract][Full Text] [Related]
53. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
54. Effect of fatty acids on glucose production and utilization in man.
Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
[TBL] [Abstract][Full Text] [Related]
55. Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women.
Nellemann B; Gormsen LC; Sørensen LP; Christiansen JS; Nielsen S
Obesity (Silver Spring); 2012 Jan; 20(1):57-64. PubMed ID: 21959346
[TBL] [Abstract][Full Text] [Related]
56. Sympathoadrenal function in genetically obese Zucker rats.
Scheurink AJ; Steffens AB; Roossien B; Balkan B
Physiol Behav; 1992 Oct; 52(4):679-85. PubMed ID: 1409939
[TBL] [Abstract][Full Text] [Related]
57. Whole body lipid and energy metabolism in the cancer patient.
Legaspi A; Jeevanandam M; Starnes HF; Brennan MF
Metabolism; 1987 Oct; 36(10):958-63. PubMed ID: 3657515
[TBL] [Abstract][Full Text] [Related]
58. θ-Defensin RTD-1 improves insulin action and normalizes plasma glucose and FFA levels in diet-induced obese rats.
Oh YT; Tran D; Buchanan TA; Selsted ME; Youn JH
Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E154-60. PubMed ID: 25991648
[TBL] [Abstract][Full Text] [Related]
59. Caffeine: its effect on catecholamines and metabolism in lean and obese humans.
Jung RT; Shetty PS; James WP; Barrand MA; Callingham BA
Clin Sci (Lond); 1981 May; 60(5):527-35. PubMed ID: 7018802
[TBL] [Abstract][Full Text] [Related]
60. Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.
Andreotti AC; Lanzi R; Manzoni MF; Caumo A; Moreschi A; Pontiroli AE
Metabolism; 1994 Oct; 43(10):1207-13. PubMed ID: 7934970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
